EBRONUCIMAB
UNII CXX4Q31AAO

Substance Identification & Data

This profile provides standardized clinical and technical data for Ebronucimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CXX4Q31AAO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2304800-90-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CXX4Q31AAO
CAS Registry Number
2304800-90-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EBRONUCIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175774
National Cancer Institute reference terminology for clinical and research data.
INN ID
11476
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ebronucimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EBRONUCIMAB

Common Names & Synonyms

EBRONUCIMAB [INN]
EBRONUCIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL AK102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AK102 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HOMO SAPIENS MONOCLONAL ANTIBODY

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus